| 產(chǎn)品名稱 | CysLT1 Antagonist Q8 |
| 產(chǎn)品貨號(hào) | Axon 2738 CAS [1541762-55-3] MF C17H14ClNO2MW 299.75 Purity: 99% Soluble in DMSO Description CysLT1 antagonist Q8 inhibits developmental angiogenesis in transgenic fluorescent zebrafish, and inhibits human microvascular endothelial cell (HMEC-1) proliferation, tubule formation, and migration. CysLT1 antagonist Q8 elicits antiangiogenic effects in a VEGF-independent in vitro model of angiogenesis and exerts an additive antiangiogenic response with the anti-VEGF biologic bevacizumab. KEYWORDS: CysLT1 Antagonist Q8 | supplier | CysLT1 antagonist | CAS [1541762-55-3] | [1541762-52-0] | Cysteinyl leukotrienes | CysLT | Antagonist | Receptors | Angiogenesis | Antiangiogenic |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
CysLT1 Antagonist Q8Axon 2738 CAS [1541762-55-3] MF C17H14ClNO2
DescriptionCysLT1 antagonist Q8 inhibits developmental angiogenesis in transgenic fluorescent zebrafish, and inhibits human microvascular endothelial cell (HMEC-1) proliferation, tubule formation, and migration. CysLT1 antagonist Q8 elicits antiangiogenic effects in a VEGF-independent in vitro model of angiogenesis and exerts an additive antiangiogenic response with the anti-VEGF biologic bevacizumab. KEYWORDS: CysLT1 Antagonist Q8 | supplier | CysLT1 antagonist | CAS [1541762-55-3] | [1541762-52-0] | Cysteinyl leukotrienes | CysLT | Antagonist | Receptors | Angiogenesis | Antiangiogenic
Antagonist of the cysteinyl leukotriene receptor 1 (CysLT1)
Chemical name(E)-2-(2-(Quinolin-2-yl)vinyl)benzene-1,4-diol hydrochloride Parent CAS No.[1541762-52-0] |
| 產(chǎn)品資料 |
